Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Mosaic Therapeutics in-licenses Two Clinical-stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies

  • In-licensing transforms Mosaic from a research and platform company to a clinical-stage oncology business
  • Mosaic will develop proprietary, targeted combination products, supported by proprietary biomarkers, to realise the full potential of the assets
  • As part of the agreement Astex has taken an equity stake in Mosaic

Milner Therapeutics Symposium 2025

The Milner Therapeutics Symposium takes place annually in Cambridge, UK, hosting ~500 delegates in person and >250 online. The Symposium is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma and biotech towards new treatments. It is our key networking event to foster collaborations within the Milner Therapeutics Institute partner organisations.

How Should Future Skills Strategies Be Shaped?



by Monalisa Breazu, Learning & Development Administrator, One Nucleus

At a recent One Nucleus roundtable, a diverse group of professionals came together to talk candidly about this exact issue. From HR and hiring leads to scientists, educators, and entrepreneurs, we unpacked what’s working, what’s broken, and what needs to change.

Here’s what we learned and what we need to start doing differently.

Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test

  • Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients
  • EvoLiver leverages Mursla Bio’s platform based on organ-specific extracellular vesicles circulating in blood
  • Breakthrough status provides expedited review and closer collaboration with the FDA, ultimately enabling broader market reach and commercial adoption

EA/Administration Manager

Location: Chesterford Research Park

Position & Purpose

  • To be the key point of contact, gatekeeper and company representative on behalf of the CEO, Site Head and the leadership team
  • To ensure the two UK offices are run efficiently and that staff at both sites have the resources and facilities required
  • To provide administration support to CEO and senior leadership team

General Tasks & Responsibilities

2025 BioCap Conference

Whether you're looking to invest in the next breakthrough in life sciences or seeking funding opportunities for your business, BioCap is THE date for your diary!

BioCap offers three exciting opportunities for investors and businesses to connect:

Tuesday 23rd September: BioCap Digital Pitching Competition – Online
Wednesday 24th September: BioCap Investors Mixer – Alderley Park
Thursday 25th September: BioCap Conference – Alderley Park

Bionow Neuroscience Conference

The Bionow Neuroscience conference, now in its second year after the success of 2024, will bring together academics, clinicians and industry experts in the spirit of collaboration and growth.

Conference sessions aim to highlight the strengths in the discovery, development and commercialisation of neuroscience treatments and technologies across the north of England and beyond. The event will showcase key developments across neuroscience, including a range of neurological diseases and conditions.

2025 BioFocus Conference

BioFocus is a one-day conference that brings together industry, academia, and experts in life sciences. BioFocus will inspire your business to connect, engage, benefit and grow. Comprising conference, exhibition, and significant networking sessions, this event will provide a unique opportunity to hear about the latest technologies, innovations, key sector initiatives, and funding opportunities.

Subscribe to